文献速递临床试验与 GCP流行病学与生物统计

妊娠期高血压后通过医生优化自我管理的长期血压控制:POP-HT随机临床试验

Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management: The POP-HT Randomized Clinical Trial.
PubMed 文献 · JAMA · 2023-01-01

这项在英国单中心开展的随机、开放标签、盲法终点试验纳入220名产后需服用降压药的子痫前期或妊娠期高血压患者,1:1分配至自我监测联合医生优化降压滴定组或常规产后护理组。产后9个月时,干预组24小时平均舒张压较对照组低5.8 mm Hg,收缩压低6.5 mm Hg,差异均具有统计学意义。

要点

  • 产后自我监测联合医生优化降压滴定较常规护理显著降低9个月时24小时平均舒张压和收缩压。
  • 干预组24小时平均舒张压71.2 mm Hg vs 对照组76.6 mm Hg,组间差异-5.80 mm Hg(95%CI -7.40至-4.20;P<.001)。
  • 干预组24小时平均收缩压114.0 mm Hg vs 对照组120.3 mm Hg,组间差异-6.51 mm Hg(95%CI -8.80至-4.22;P<.001)。

核心结论

  • 在这项单中心试验中,自我监测联合医生指导的降压药物滴定与英国常规产后门诊护理相比,与产后前9个月更低的血压相关。

研究设计与样本

  • 随机、开放标签、盲法终点试验,设于英国一家医院。
  • 纳入年龄18岁及以上、妊娠合并子痫前期或妊娠期高血压、出院时需产后服用降压药者。
  • 220名参与者按1:1随机分配至干预组(n=112)或对照组(n=108)。
  • 首次入组于2020年2月21日,末次随访于2021年11月2日,随访期约9个月。
  • 200名参与者(91%)纳入主要分析。

主要发现

  • 参与者平均(SD)年龄32.6(5.0)岁,40%为妊娠期高血压,60%为子痫前期。
  • 产后249(16)天测得的24小时平均(SD)舒张压:干预组71.2(5.6)mm Hg vs 对照组76.6(5.7)mm Hg,干预组低5.8 mm Hg,组间差异-5.80 mm Hg(95%CI -7.40至-4.20;P<.001)。
  • 24小时平均(SD)收缩压:干预组114.0(7.7)mm Hg vs 对照组120.3(9.1)mm Hg,干预组低6.5 mm Hg,组间差异-6.51 mm Hg(95%CI -8.80至-4.22;P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文在结论中写明该试验为单中心试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Pregnancy hypertension results in adverse cardiac remodeling and higher incidence of hypertension and cardiovascular diseases in later life. OBJECTIVE: To evaluate whether an intervention designed to achieve better blood pressure control in the postnatal period is associated with lower blood pressure than usual outpatient care during the first 9 months postpartum. DESIGN, SETTING, AND PARTICIPANTS: Randomized, open-label, blinded, end point trial set in a single hospital in the UK. Eligible participants were aged 18 years or older, following pregnancy complicated by preeclampsia or gestational hypertension, requiring antihypertensive medication postnatally when discharged. The first enrollment occurred on February 21, 2020, and the last follow-up, November 2, 2021. The follow-up period was approximately 9 months. INTERVENTIONS: Participants were randomly assigned 1:1 to self-monitoring along with physician-optimized antihypertensive titration or usual postnatal care. MAIN OUTCOMES AND MEASURES: The primary outcome was 24-hour mean diastolic blood pressure at 9 months postpartum, adjusted for baseline postnatal blood pressure. RESULTS: Two hundred twenty participants were randomly assigned to either the intervention group (n = 112) or the control group (n = 108). The mean (SD) age of participants was 32.6 (5.0) years, 40% had gestational hypertension, and 60% had preeclampsia. Two hundred participants (91%) were included in the primary analysis. The 24-hour mean (SD) diastolic blood pressure, measured at 249 (16) days postpartum, was 5.8 mm Hg lower in the intervention group (71.2 [5.6] mm Hg) than in the control group (76.6 [5.7] mm Hg). The between-group difference was -5.80 mm Hg (95% CI, -7.40 to -4.20; P < .001). Similarly, the 24-hour mean (SD) systolic blood pressure was 6.5 mm Hg lower in the intervention group (114.0 [7.7] mm Hg) than in the control group (120.3 [9.1] mm Hg). The between-group difference was -6.51 mm Hg (95% CI, -8.80 to -4.22; P < .001). CONCLUSIONS AND RELEVANCE: In this single-center trial, self-monitoring and physician-guided titration of antihypertensive medications was associated with lower blood pressure during the first 9 months postpartum than usual postnatal outpatient care in the UK. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04273854.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Kitt J, Fox R, Frost A, et al. Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management: The POP-HT Randomized Clinical Trial. JAMA. 2023. PMID: 37950919. doi:10.1001/jama.2023.21523

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。